ATRALIN Drug Patent Profile
✉ Email this page to a colleague
When do Atralin patents expire, and when can generic versions of Atralin launch?
Atralin is a drug marketed by Dow Pharm and is included in one NDA.
The generic ingredient in ATRALIN is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atralin
A generic version of ATRALIN was approved as tretinoin by PADAGIS US on December 24th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATRALIN?
- What are the global sales for ATRALIN?
- What is Average Wholesale Price for ATRALIN?
Summary for ATRALIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 140 |
Clinical Trials: | 6 |
Drug Prices: | Drug price information for ATRALIN |
What excipients (inactive ingredients) are in ATRALIN? | ATRALIN excipients list |
DailyMed Link: | ATRALIN at DailyMed |
Recent Clinical Trials for ATRALIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Zeichner, Joshua, M.D. | Phase 4 |
Johns Hopkins University | Phase 2 |
Bausch Health Americas, Inc. | Phase 3 |
Pharmacology for ATRALIN
Drug Class | Retinoid |
US Patents and Regulatory Information for ATRALIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dow Pharm | ATRALIN | tretinoin | GEL;TOPICAL | 022070-001 | Jul 26, 2007 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ATRALIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Dow Pharm | ATRALIN | tretinoin | GEL;TOPICAL | 022070-001 | Jul 26, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ATRALIN
See the table below for patents covering ATRALIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 901657 | ⤷ Sign Up | |
European Patent Office | 0393904 | ⤷ Sign Up | |
Poland | 284811 | ⤷ Sign Up | |
Australia | 5296890 | ⤷ Sign Up | |
New Zealand | 233153 | MOISTURISING VEHICLE FOR THE TOPICAL APPLICATION OF VITAMIN A IN ACID FORM | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ATRALIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1304992 | 122013000081 | Germany | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322 |
1304992 | 2013C/060 | Belgium | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506 |
1304992 | CR 2013 00053 | Denmark | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322 |
0617614 | SPC/GB01/014 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ALITRETINOIN; REGISTERED: UK EU/1/00/149/001 20001018 |
1304992 | SPC/GB13/061 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |